Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prognostic Factors
100%
Free-free
100%
Disease-free
100%
Relapse-free Survival
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Graft-versus-host Disease (GvHD)
100%
Disease Relapse
100%
Poor Outcome
40%
Adult Patients
20%
Overall Survival
20%
Novel Composite
20%
Disease-free Survival
20%
Major Complications
20%
Systemic Therapy
20%
Composite Endpoint
20%
Hematopoietic Stem Cell Transplantation
20%
Hematological Diseases
20%
Hematological Malignancies
20%
Relapsed Patients
20%
Medicine and Dentistry
Prognostic Factor
100%
Graft Versus Host Reaction
100%
Recurrence Free Survival
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Overall Survival
12%
Disease Free Survival
12%
Systemic Therapy
12%
Acute Graft Versus Host Disease
12%
Hematopoietic Stem Cell Transplantation
12%
Chronic Graft Versus Host Disease
12%
Hematologic Malignancy
12%
Blood Disorder
12%
Immunology and Microbiology
Recurrence Free Survival
100%
Graft-Versus-Host Disease
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Overall Survival
12%
Disease Free Survival
12%
Hematopoietic Stem Cell Transplantation
12%
Acute Graft Versus Host Disease
12%
Chronic Graft Versus Host Disease
12%